Cargando…
Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509018/ https://www.ncbi.nlm.nih.gov/pubmed/32767278 http://dx.doi.org/10.1007/s13300-020-00900-3 |
| _version_ | 1783585514991910912 |
|---|---|
| author | Brooks, Anne B. Langer, Jakob Tervonen, Tommi Peter Hemmingsen, Mads Eguchi, Kosei Bacci, Elizabeth D. |
| author_facet | Brooks, Anne B. Langer, Jakob Tervonen, Tommi Peter Hemmingsen, Mads Eguchi, Kosei Bacci, Elizabeth D. |
| author_sort | Brooks, Anne B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7509018 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75090182020-10-05 Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” Brooks, Anne B. Langer, Jakob Tervonen, Tommi Peter Hemmingsen, Mads Eguchi, Kosei Bacci, Elizabeth D. Diabetes Ther Letter Springer Healthcare 2020-08-07 2020-10 /pmc/articles/PMC7509018/ /pubmed/32767278 http://dx.doi.org/10.1007/s13300-020-00900-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Letter Brooks, Anne B. Langer, Jakob Tervonen, Tommi Peter Hemmingsen, Mads Eguchi, Kosei Bacci, Elizabeth D. Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” |
| title | Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” |
| title_full | Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” |
| title_fullStr | Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” |
| title_full_unstemmed | Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” |
| title_short | Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” |
| title_sort | response to “letter to the editor regarding: patient preferences for glucagon-like peptide-1 (glp-1) receptor agonist treatment of type 2 diabetes mellitus in japan: a discrete choice experiment” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509018/ https://www.ncbi.nlm.nih.gov/pubmed/32767278 http://dx.doi.org/10.1007/s13300-020-00900-3 |
| work_keys_str_mv | AT brooksanneb responsetolettertotheeditorregardingpatientpreferencesforglucagonlikepeptide1glp1receptoragonisttreatmentoftype2diabetesmellitusinjapanadiscretechoiceexperiment AT langerjakob responsetolettertotheeditorregardingpatientpreferencesforglucagonlikepeptide1glp1receptoragonisttreatmentoftype2diabetesmellitusinjapanadiscretechoiceexperiment AT tervonentommi responsetolettertotheeditorregardingpatientpreferencesforglucagonlikepeptide1glp1receptoragonisttreatmentoftype2diabetesmellitusinjapanadiscretechoiceexperiment AT peterhemmingsenmads responsetolettertotheeditorregardingpatientpreferencesforglucagonlikepeptide1glp1receptoragonisttreatmentoftype2diabetesmellitusinjapanadiscretechoiceexperiment AT eguchikosei responsetolettertotheeditorregardingpatientpreferencesforglucagonlikepeptide1glp1receptoragonisttreatmentoftype2diabetesmellitusinjapanadiscretechoiceexperiment AT baccielizabethd responsetolettertotheeditorregardingpatientpreferencesforglucagonlikepeptide1glp1receptoragonisttreatmentoftype2diabetesmellitusinjapanadiscretechoiceexperiment |